Endoluxe Enters Into Multi-year USA Distribution Agreement With Dornier MedTech for Urology Segment

Endoluxe announced that they have entered into a multi-year exclusive distribution agreement specifically for the urology market with Dornier MedTech. Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value.

“We are absolutely ecstatic to partner with Dornier MedTech to address the growing demands for better imaging solutions in urology,” states CEO Devon Bream. “Coming out of the American Urology Association (AUA) conference last month, we knew from the amount of exhibit buzz around Endoluxe that the time was right to select a market leading partner to help us grow our existing urology business. Dornier MedTech is an excellent partner to work with and we appreciate their support of our platform.”

The Endoluxe EVS is the perfect camera system for all endoscopic procedures that utilize industry standard rigid and flexible analogue scopes such as urology, gynecology, ENT, general surgery, and orthopedics. The handheld Orb replaces the legacy endoscopic tower with advanced, portable technology at 1/6 the cost. Specifically for urology, the Endoluxe Orb has a novel image stabilization functionality that benefits urologists during basic and complex urologic procedures.

“We are pleased to add the Endoluxe platform to our growing portfolio as we believe their technology represents the future of endoscopic visualization. With the various new urology products that Dornier introduced at AUA, it is an ideal situation to have Endoluxe join our portfolio of market leading urology products,” states Brock Faulkner, CEO of Dornier MedTech America.

Endoluxe is a world-class endoscopic video imaging organization based in the United States with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices, while taking advantage of future technological advancements utilizing our portable, integrated, and feature-laden platform at 1/6th the cost of legacy products.

Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech. As a pioneer in the field of urology, Dornier is one of the most trusted names in the industry. The company continues to drive clinical performance and spearhead innovation in urology, launching several pioneering technologies and revolutionary therapies in recent years.

As the world’s first MDR-certified integrated urology company, and one of the original founders of the Urology Care Foundation (formerly known as the American Foundation for Urologic Diseases), Dornier takes pride in holding to the highest standards of patient safety and product efficacy. Today, the company is pushing the envelope in digital urology to provide holistic care to patients seeking treatment and community support in their recovery journey through online and in-person channels. Trusted by thousands of physicians and patients, Dornier is committed to serving and supporting the urology community worldwide.

SourceEndoluxe

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version